The present invention relates to the use of silver(I) monophosphine complexes as Active Pharmaceutical Ingredients (API's), including anticancer agents, for the treatment, diagnosis and/or prevention of cancer. The present invention also relates to pharmaceutical compositions containing such complexes and further extends to a method of treating or diagnosing a subject/patient suffering from cancer.
本发明涉及使用
银(I)单膦配合物作为活性药物成分(A
PI),包括抗癌药物,用于治疗、诊断和/或预防癌症。本发明还涉及含有这种配合物的制药组合物,并进一步扩展到治疗或诊断患有癌症的受试者/患者的方法。